Evaluating TB/HIV Activities in Rwanda
Author Information
Author(s): Pevzner Eric S, Vandebriel Greet, Lowrance David W, Gasana Michel, Finlay Alyssa
Primary Institution: Division of TB Elimination, U.S. Centers for Disease Control and Prevention
Hypothesis
How effective was the scale-up of collaborative TB/HIV activities in Rwanda from 2005 to 2009?
Conclusion
The scale-up of TB/HIV services in Rwanda led to increased HIV testing and treatment, significantly reducing the risk of death among patients with TB/HIV.
Supporting Evidence
- 76% of patients were offered HIV testing, and 99% accepted.
- The proportion of patients with TB receiving HIV testing increased from 69% to 97% from 2005 to 2009.
- Provision of cotrimoxazole for TB/HIV patients increased from 15% to 92% during the same period.
- The risk of death among patients with TB/HIV decreased significantly from 2005 to 2007.
Takeaway
This study shows that when patients with TB are offered HIV testing, almost all accept it, which helps them get the care they need.
Methodology
The study involved structured interviews with patients and staff at 23 TB clinics and a review of patient records to assess HIV testing practices and treatment outcomes.
Potential Biases
Self-reported data may be subject to recall and social desirability bias.
Limitations
The sample may not represent all TB clinics in Rwanda, and data were based on self-reports, which could introduce bias.
Participant Demographics
Of the 207 patients interviewed, 39% were female, with a median age of 37 years.
Statistical Information
Confidence Interval
RR = 6.1, 95% CI 2.6, 14.0; RR = 1.8, 95% CI 1.68, 1.94
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website